NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 82 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -75.6% | 15,741 | -60.4% | 0.00% | – |
| Q2 2022 | $41,000 | -67.5% | 39,759 | -40.5% | 0.00% | – |
| Q1 2022 | $126,000 | -43.2% | 66,772 | +45.5% | 0.00% | – |
| Q4 2021 | $222,000 | -73.9% | 45,897 | -61.0% | 0.00% | – |
| Q3 2021 | $850,000 | -55.9% | 117,656 | -43.6% | 0.00% | – |
| Q2 2021 | $1,927,000 | -53.8% | 208,717 | -38.3% | 0.00% | -100.0% |
| Q1 2021 | $4,167,000 | +941.8% | 338,530 | +1091.0% | 0.00% | – |
| Q4 2020 | $400,000 | +205.3% | 28,423 | +160.9% | 0.00% | – |
| Q3 2020 | $131,000 | -89.3% | 10,893 | -89.9% | 0.00% | – |
| Q1 2020 | $1,224,000 | +547.6% | 107,522 | +602.6% | 0.00% | – |
| Q4 2019 | $189,000 | – | 15,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 810,073 | $9,980,000 | 6.05% |
| EcoR1 Capital, LLC | 3,915,880 | $48,244,000 | 4.35% |
| Opaleye Management Inc. | 1,381,300 | $17,018,000 | 3.34% |
| Avidity Partners Management LP | 210,000 | $2,587,000 | 1.63% |
| ACUTA CAPITAL PARTNERS, LLC | 372,500 | $4,589,000 | 1.14% |
| Boxer Capital, LLC | 1,009,255 | $12,434,000 | 0.70% |
| Redmile Group, LLC | 1,920,831 | $23,665,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 379,998 | $4,682,000 | 0.39% |
| Sio Capital Management, LLC | 88,185 | $1,086,000 | 0.26% |
| Baker Brothers Advisors | 3,397,740 | $41,860,000 | 0.22% |